Evidence map›Paper›PMID 34515777›Full record

ArticleHuman reproduction (Oxford, England)2021

Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction.

ESHRE COVID-19 Working Group, Baris Ata, Luca Gianaroli, Kersti Lundin, Saria Mcheik, Edgar Mocanu, Satu Rautakallio-Hokkanen, Juha S Tapanainen, Nathalie Vermeulen, Anna Veiga

Open access · hybridAbstract read
In one paragraph

Article in Human reproduction (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. SARS-CoV-2 can infect human embryos.Scientific reports · 2022
    Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 6 countries.

ESHRE COVID-19 Working Group
Baris AtaObstetrics and Gynecology Department, Koc University, Istanbul, Turkey.ORCID 0000-0003-1106-3747
Luca GianaroliSocietà Italiana Studi di Medicina della Riproduzione, S.I.S.Me.R. Reproductive Medicine Institute, Bologna, Emilia-Romagna, Italy.
Kersti LundinReproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Saria McheikEuropean Society of Human Reproduction and Embryology (ESHRE) Central Office, Grimbergen, Belgium.
Edgar MocanuDepartment of Reproductive Medicine, Rotunda Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland.
Satu Rautakallio-HokkanenFertility Europe Evere, Evere, Belgium.
Juha S TapanainenDepartment of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Nathalie VermeulenEuropean Society of Human Reproduction and Embryology (ESHRE) Central Office, Grimbergen, Belgium.
Anna VeigaReproductive Medicine Service, Dexeus Mujer, Hospital Universitari Dexeus/Institut d'Investigació Biomedica de Bellvitge, IDIBELL, Barcelona Stem Cell Bank, Regenerative Medicine Programme, Barcelona, Spain.
Institut d'Investigació Biomédica de Bellvitge · ESKoç University · TRRoyal College of Surgeons in Ireland · IESahlgrenska University Hospital · SEUniversity of Helsinki · FI

Funding

ESHRE
6 · The paper itself

Abstract

study questionWhat is the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcome of a pregnancy after medically assisted reproduction (MAR)? SUMMARY ANSWER: Our results suggest that MAR pregnancies are not differentially affected by SARS-CoV-2 infection compared to spontaneous pregnancies. WHAT IS KNOWN ALREADY: Information on the effects of coronavirus disease 2019 (COVID-19) on pregnancy after MAR is scarce when women get infected during MAR or early pregnancy, even though such information is vital for informing women seeking pregnancy. STUDY DESIGN, SIZE, DURATION: Data from SARS-CoV-2 affected MAR pregnancies were collected between May 2020 and June 2021 through a voluntary data collection, organised by the European Society of Human Reproduction and Embryology (ESHRE). PARTICIPANTS/MATERIALS, SETTING,

methodsAll ESHRE members were invited to participate to an online data collection for SARS-CoV-2-infected MAR pregnancies. MAIN RESULTS AND THE ROLE OF CHANCE: The dataset includes 80 cases from 32 countries, including 67 live births, 10 miscarriages, 2 stillbirths and 1 maternal death. An additional 25pregnancies were ongoing at the time of writing. LIMITATIONS, REASONS FOR CAUTION: An international data registry based on voluntary contribution can be subject to selective reporting with possible risks of over- or under-estimation. WIDER IMPLICATIONS OF THE

findingsThe current data can be used to guide clinical decisions in the care of women pregnant after MAR, in the context of the COVID-19 pandemic. STUDY FUNDING/COMPETING INTEREST(S): The authors acknowledge the support of ESHRE for the data registry and meetings. J.S.T. reports grants or contracts from Sigrid Juselius Foundation, EU and Helsinki University Hospital Funds, outside the scope of the current work. The other authors declare that they have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

Indexed as

Abortion, SpontaneousCOVID-19FemaleHumansPandemicsPregnancyReproductionSARS-CoV-2COVID-19ESHREIVFmedically assisted reproductionpregnancySARS-CoV-2

Identifiers

PMID34515777
PMCPMC8523208
OpenAlexW3201494260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.